<

 
Data updated 2025-05-30 00:05:01
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date14722450.5 (espacenet)  (Federated)  (European Patent Register), 20140314
Patent/reg. no. and dateDK/EP 2968588, 20190109
Publication date20160120
Priority no. and dateUS 201361790490 P, 20130315
EP pub. no. and date EP 2968588 20160120
Effective date
Applicant/ownerAbbVie Inc., 1 North Waukegan Road
North Chicago, IL 60064, US,
Abbvie Deutschland GmbH & Co. KG, Max-Planck-Ring 2a
65205 Wiesbaden, DE
Applicant ref. no.P24150DKEP
InventorKUMAR, Vineet, 126 Courtyard Lane
Storrs, CT 06268, US,
TSCHOEPE, Markus, Lindenweg 4
67258 Hessheim, DE,
KALETA, Katharina, Adolf-Diesterweg-Strasse 107
67071 Ludwigshafen, DE
RepresentativePatrade A/S, Ceresbyen 75, 8000 Århus C
Opponent
IPC ClassA61K 47/68 (2017.01) , A61K 9/19 (2006.01) , A61P 35/00 (2006.01) 
TitleANTI-EGFR-ANTISTOF-LÆGEMIDDEL-KONJUGAT-FORMULERINGER
Int. application no.US2014027868
Int. publication no.WO2014143765
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact